CNBC
3 weeks ago
Eli Lilly's weight loss drugs trounce sky-high expectations, boosting the stock
The weight loss medication market is shaping up to be a duopoly of Eli Lilly and Novo Nordisk, analysts said.
Latest News
Ex-Pfizer employee charged with illegal trading based on unreleased Covid pill trial data
3 weeks ago
CDC recommends RSV vaccines from Pfizer, GSK for adults 60 and older
3 weeks ago
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
4 days ago
Kenvue shares fall even as J&J spinoff beats estimates in first quarterly earnings since IPO
2 days ago
Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know
2 days ago